J Gerstoft

Ischemic Heart Disease in HIV-Infected and HIV-Uninfected Individuals: A Population-Based Cohort Study

Niels Obel, Henrik F. Thomsen, Gitte Kronborg et al. · Clinical Infectious Diseases · 2007 · 333 citations

Medicine, Cardiology, Infectious Diseases +17

Ritonavir-Boosted Tipranavir Demonstrates Superior Efficacy to Ritonavir-Boosted Protease Inhibitors in Treatment-Experienced HIV-Infected Patients: 24-Week Results of the RESIST-2 Trial

Pedro Cahn, Jorge Villacian, Adriano Lazzarin et al. · Clinical Infectious Diseases · 2006 · 81 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Bone mineral density changes in protease inhibitor-sparing vs. nucleoside reverse transcriptase inhibitor-sparing highly active antiretroviral therapy: data from a randomized trial*

Niels Obel, Henrik Nielsen, C Pedersen et al. · HIV Medicine · 2010 · 64 citations · Full text

Medicine, Pharmacotherapy, Bone Metabolism +16

The effect of foscarnet (phosphonoformate) on human immunodeficiency virus isolation, T-cell subsets and lymphocyte function in AIDS patients.

Janne E. Gaub, Carsten Bøcker Pedersen, Poulsen Ag et al. · PubMed · 1987 · 44 citations

Life Sciences, Immunology, Infectious Diseases +17

Causes of death among Danish HIV patients compared with population controls in the period 1995–2008

Marie Helleberg, Gitte Kronborg, Carsten Schade Larsen et al. · Infection · 2012 · 43 citations

Public Health, Immunology, Infectious Diseases +12